GRP78 participates in PCA3-regulated prostate cancer progression

N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Background/Aim: The human prostate cancer antigen 3 (PCA3) is a long non-coding RNA (lncRNA) commonly used as a diagnostic marker for prostate cancer (PCA). Herein we investigated the cellular function of PCA3 in PCA and its potential mechanism. Materials and Methods: PCA3 was overexpressed in a PC3 cell line (PC3PCA+) and cell proliferation, migration, invasion and apoptosis were compared to those of control cells (PC3NC). Differentially expressed proteins were identified by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and mass spectrometry. Results: Overexpression of PCA3 significantly increased cell proliferation rate, migration and invasion, while inhibited apoptosis in PC3 cells. Three proteins were found down-regulated and 7 proteins up-regulated in PC3PCA+ cells compared to PC3NC cells, including GRP78. Higher GRP78 was also found in PCA clinical specimens. Conclusion: This study confirmed that in PCA, PCA3 plays a pro-cancer role through promoting cell proliferation, migration and invasion while inhibiting cell apoptosis. This process might involve the up-regulation of GRP78.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lin, C., Wang, J., Wang, Y., Zhu, P., Liu, X., Li, N., … Wang, W. (2017). GRP78 participates in PCA3-regulated prostate cancer progression. In Anticancer Research (Vol. 37, pp. 4303–4310). International Institute of Anticancer Research. https://doi.org/10.21873/anticanres.11823

Readers over time

‘17‘18‘20‘23‘24‘2500.751.52.253

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

67%

Researcher 1

33%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 2

40%

Medicine and Dentistry 1

20%

Computer Science 1

20%

Chemistry 1

20%

Save time finding and organizing research with Mendeley

Sign up for free
0